Delivery Order SPE2DR25D1002-SPE2DR26FGM5V
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,102.87 by the Defense Logistics Agency (DLA) on January 8, 2026, for Shingrix vial kits with an ultimate completion date of January 9, 2026. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award through open competition. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $88,596.12 by the Defense Logistics Agency on January 6, 2026, for the supply of Shingrix vial kits. The award is a firm fixed-price contract with an ultimate completion date of January 7, 2026, and represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This IDC, valued at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,587.57 for Shingrix vial kits by the Defense Logistics Agency (DLA) on January 2, 2026, with a completion deadline of January 5, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,236.30 by the Defense Logistics Agency on August 25, 2025, for Shingrix vial kits with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract represents a small-value transaction typical of the company's extensive portfolio of medical product deliveries to federal healthcare systems. The delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,374.50 for Shingrix vial kits under a Firm Fixed Price contract by the Defense Logistics Agency's Medical Supply Chain on September 19, 2025, with an ultimate completion date of September 22, 2025. The award carries no set-aside designation and represents a competitive procurement. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,139.18 for Shingrix vial kits on May 14, 2025, with an ultimate completion date of May 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits on November 20, 2025, with a ceiling value of $1,918.75 and an ultimate completion date of November 21, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on January 2, 2026, for the supply of Shingrix vaccine vial kits with a ceiling value of $4,197.53. The contract is firm fixed price with an ultimate completion date of January 5, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made without a set-aside designation, indicating it was competitively awarded through open competition. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 18, 2025, for the supply of Shingrix vial kits, a recombinant zoster vaccine. This non-set-aside, competitively awarded contract has a ceiling value of $1,102.87 with a firm fixed price structure and an ultimate completion date of December 19, 2025. The delivery order is performed at the contractor's Corporate Office location in Conshohocken,...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,357.35 by the Defense Logistics Agency (DLA) for Shingrix vial kits, with an ultimate completion date of August 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader federal contracting relationship with DLA. This award falls...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGM5VDelivery Order
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 8, 2026, for Shingrix vial kits with a ceiling value of $1,198.97. This is a firm fixed-price delivery order with an ultimate completion date of January 9, 2026, and does not utilize a set-aside designation. The award was made through open competition, consistent with Amerisourcebergen's established track record as a critical vendor for federal medical procurement. This delivery order is executed under Amerisourcebergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies, including vaccines, to support military healthcare programs globally. Shingrix, a recombinant zoster vaccine, supports the Defense Health Agency's immunization requirements across military treatment facilities and healthcare systems. The parent company, Cencora, Inc. (doing business as Amerisourcebergen), holds the underlying $999,999,999.00 IDC with DLA through December 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/7/26 |